Talia Technology Ltd., which develops and markets retinal imaging and diagnostic equipment for screening, diagnosis and follow-up of common retinal diseases, expects to raise £10 million ($19 million) at a company value of £30 million ($57 million), after money on London's Alternative Investment Market (AIM). UK investment house Code Securities Ltd. is the underwriter.
"The Financial Times" reports that Talia Technology plans to use the proceeds from the issue to expand its basket of products and improve its marketing.
Talia Technology CEO Dan Moran had said previously, "The issue in London will enable the company to expand its activities, and develop additional applications for its various devices."
Talia Technology develops imaging systems for the retina and a device for diagnosing and treating ophthalmic diseases. Its flagship product, the Retina Thickness Analyzer (RTA), is designed to diagnose three of the commonest retina diseases before they develop: glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy, a diabetes complication affecting the retina.
Published by Globes [online], Israel business news - www.globes.co.il - on April 26, 2005